Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer
暂无分享，去创建一个
A. Ravaud | M. Shi | V. Grünwald | Chia‐Chi Lin | M. Squires | D. Castellano | A. Harzstark | J. Gschwend | B. Escudier | Y. Ou | E. Angevin | N. Pirotta | S. Beall